Rothschild Capital Partners LLC Purchases New Position in Tema Heart & Health ETF $HRTS

Rothschild Capital Partners LLC acquired a new stake in Tema Heart & Health ETF (NASDAQ:HRTS) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 24,512 shares of the company’s stock, valued at approximately $651,000. Rothschild Capital Partners LLC owned 1.65% of Tema Heart & Health ETF at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Citadel Advisors LLC acquired a new stake in Tema Heart & Health ETF in the third quarter valued at approximately $243,000. Stifel Financial Corp grew its holdings in Tema Heart & Health ETF by 19.8% during the 4th quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock valued at $1,187,000 after purchasing an additional 5,571 shares in the last quarter. Jane Street Group LLC increased its stake in Tema Heart & Health ETF by 9.4% during the 2nd quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after buying an additional 3,202 shares during the period. JPMorgan Chase & Co. acquired a new position in Tema Heart & Health ETF in the 2nd quarter worth $63,000. Finally, Royal Bank of Canada lifted its holdings in Tema Heart & Health ETF by 8.8% in the 1st quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after buying an additional 1,703 shares in the last quarter.

Tema Heart & Health ETF Price Performance

Shares of Tema Heart & Health ETF stock opened at $37.64 on Monday. Tema Heart & Health ETF has a 1-year low of $29.45 and a 1-year high of $38.87. The company has a market capitalization of $56.08 million, a PE ratio of 22.06 and a beta of 0.63. The business has a 50-day moving average of $36.89 and a 200-day moving average of $35.15.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.